LEADER 01272nam 2200337 n 450 001 996391889203316 005 20221107234259.0 035 $a(CKB)1000000000672658 035 $a(EEBO)2240891197 035 $a(UnM)99837761 035 $a(EXLCZ)991000000000672658 100 $a19901016d1611 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 12$aA treatise of vsurie$b[electronic resource] $ediuided into three bookes: the first defineth what is vsurie. The second determineth that to be vnlawfull. The third remoueth such motiues as perswade men in this age that it may be lawfull. By Robert Fenton Bachelar of Diuinitie 210 $aAt London $cImprinted by Felix Kyngston, for VVilliam Aspley$d1611 215 $a[16], 155, [1] p 300 $aThe first leaf is blank. 300 $aReproduction of the original in the Henry E. Huntington Library and Art Gallery. 330 $aeebo-0113 606 $aUsury$xReligious aspects$vEarly works to 1800 615 0$aUsury$xReligious aspects 700 $aFenton$b Roger$f1565-1616.$01004856 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bWaOLN 906 $aBOOK 912 $a996391889203316 996 $aA treatise of vsurie$92312359 997 $aUNISA LEADER 03640nam 2200721 a 450 001 9910954475903321 005 20251017110220.0 010 $a9786611300241 010 $a9780309178280 010 $a0309178282 010 $a9781281300249 010 $a1281300241 010 $a9780309108904 010 $a030910890X 035 $a(CKB)1000000000714270 035 $a(SSID)ssj0000282269 035 $a(PQKBManifestationID)11233192 035 $a(PQKBTitleCode)TC0000282269 035 $a(PQKBWorkID)10317941 035 $a(PQKB)11471156 035 $a(MiAaPQ)EBC3378339 035 $a(Au-PeEL)EBL3378339 035 $a(CaPaEBR)ebr10225182 035 $a(CaONFJC)MIL130024 035 $a(OCoLC)923278624 035 $a(Perlego)4734007 035 $a(DNLM)1472855 035 $a(BIP)17176889 035 $a(EXLCZ)991000000000714270 100 $a20081106d2008 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNeuroscience biomarkers and biosignatures $econverging technologies, emerging partnerships : workshop summary /$fMiriam Davis, Sarah Hanson, Bruce Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$d2008 215 $axi, 115 p. $cill 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9780309108898 311 08$a0309108896 320 $aIncludes bibliographical references. 327 $aBiomarkers and biosignature principles -- Potential tools for biomarker and biosignature development -- Psychiatric tools and drug addiction disorders -- Neurological and eye diseases. 330 $aBiomarkers, or biological markers, are quantitative measurements that offer researchers and clinicians valuable insight into diagnosis, treatment and prognosis for many disorders and diseases. A major goal in neuroscience medical research is establishing biomarkers for disorders of the nervous system. Given the promising potential and necessity for neuroscience biomarkers, the Institute of Medicine Forum on Neuroscience and Nervous System Disorders convened a public workshop and released the workshop summary entitled Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships. The workshop brought together experts from multiple areas to discuss the most promising and practical arenas in neuroscience in which biomarkers will have the greatest impact. The main objective of the workshop was to identify and discuss biomarker targets that are not currently being aggressively pursued but that could have the greatest near-term impact on the rate at which new treatments are brought forward for psychiatric and neurological disorders. 517 1 $aForum on Neuroscience and Nervous System Disorders 606 $aBiochemical markers 606 $aNeurosciences 615 0$aBiochemical markers. 615 0$aNeurosciences. 676 $a612.8 701 $aDavis$b Miriam$c(Medical writer)$0856948 701 $aHanson$b Sarah L$g(Sarah Lynn),$f1980-$01811180 701 $aAltevogt$b Bruce M$01791694 712 02$aNational Research Council (U.S.) 712 02$aInstitute of Medicine (U.S.).$bForum on Neuroscience and Nervous System Disorders. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910954475903321 996 $aNeuroscience biomarkers and biosignatures$94362885 997 $aUNINA